PHARMAEXPRESS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMAEXPRESS
Largest movements
- Financial fixed assets +€215,989
up €215,989 (+59.2%), from €365,109 to €581,098
- Receivables within one year -€186,222
down €186,222 (-99.7%), from €186,851 to €629
of which Trade receivables: -€177,651
- Profit (loss) carried forward +€162,647
up €162,647, from -€86,334 to €76,313
- Tax, wage and social debts -€127,476
down €127,476 (-96.2%), from €132,579 to €5,103
of which Taxes: -€73,273
- Trade debts -€7,562
down €7,562 (-90.8%), from €8,332 to €770
- Gross operating margin -€426,948
down €426,948 (-51.7%), from €826,330 to €399,381
- Turnover -€353,134
down €353,134 (-45.2%), from €781,847 to €428,713
- Staff costs -€216,968
down €216,968 (-50.8%), from €427,415 to €210,447
- Purchases and services -€76,059
down €76,059 (-68.7%), from €110,764 to €34,705
- Taxes +€33,103
new in 2025: €33,103
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €554,577 | €582,187 | +€27,609 | +5.0% |
| Fixed assets | 21/28 | €365,109 | €581,098 | +€215,989 | +59.2% |
| Financial fixed assets | 28 | €365,109 | €581,098 | +€215,989 | +59.2% |
| Current assets | 29/58 | €189,468 | €1,089 | -€188,380 | -99.4% |
| Amounts receivable within one year | 40/41 | €186,851 | €629 | -€186,222 | -99.7% |
| Trade receivables | 40 | €177,651 | - | -€177,651 | |
| Other amounts receivable | 41 | €9,200 | €629 | -€8,571 | -93.2% |
| Cash at bank and in hand | 54/58 | €204 | €460 | +€256 | +125.4% |
| Deferred charges and accrued income | 490/1 | €2,413 | - | -€2,413 | |
| Total equity and liabilities | 10/49 | €554,577 | €582,187 | +€27,609 | +5.0% |
| Equity | 10/15 | €413,666 | €576,313 | +€162,647 | +39.3% |
| Contributions | 10/11 | €500,000 | €500,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€86,334 | €76,313 | +€162,647 | |
| Amounts payable | 17/49 | €140,911 | €5,873 | -€135,038 | -95.8% |
| Amounts payable within one year | 42/48 | €140,911 | €5,873 | -€135,038 | -95.8% |
| Trade debts | 44 | €8,332 | €770 | -€7,562 | -90.8% |
| Suppliers | 440/4 | €8,332 | €770 | -€7,562 | -90.8% |
| Taxes, remuneration and social security | 45 | €132,579 | €5,103 | -€127,476 | -96.2% |
| Taxes | 450/3 | €78,377 | €5,103 | -€73,273 | -93.5% |
| Remuneration and social security | 454/9 | €54,202 | - | -€54,202 | |
| Accrued charges and deferred income | 492/3 | €0 | €0 | = | 0.0% |
| Turnover | 70 | €781,847 | €428,713 | -€353,134 | -45.2% |
| Non-recurring operating income | 76A | €155,247 | €5,373 | -€149,874 | -96.5% |
| Goods, raw materials, services and sundry goods | 60/61 | €110,764 | €34,705 | -€76,059 | -68.7% |
| Remuneration, social security and pensions | 62 | €427,415 | €210,447 | -€216,968 | -50.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,552 | - | -€4,552 | |
| Other operating charges | 640/8 | €39 | €21 | -€18 | -46.7% |
| Non-recurring operating charges | 66A | €75,346 | - | -€75,346 | |
| Gross operating margin | 9900 | €826,330 | €399,381 | -€426,948 | -51.7% |
| Operating profit (loss) | 9901 | €318,978 | €188,914 | -€130,065 | -40.8% |
| Financial income | 75/76B | €4,598 | €12,098 | +€7,500 | +163.1% |
| Recurring financial income | 75 | €4,598 | €12,098 | +€7,500 | +163.1% |
| Financial charges | 65/66B | €7,852 | €5,261 | -€2,591 | -33.0% |
| Recurring financial charges | 65 | €7,852 | €5,261 | -€2,591 | -33.0% |
| Profit (loss) for the period before taxes | 9903 | €315,724 | €195,750 | -€119,974 | -38.0% |
| Income taxes | 67/77 | - | €33,103 | +€33,103 | |
| Profit (loss) for the period | 9904 | €315,724 | €162,647 | -€153,078 | -48.5% |
| Profit (loss) for the period to be appropriated | 9905 | €315,724 | €162,647 | -€153,078 | -48.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.